Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
Thermo Fisher Scientific Inc ( NYSE:TMO) demonstrates robust financial health with increased net income despite a slight revenue dip. Recent acquisitions and strategic investments position TMO for diversified growth and enhanced market presence.
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Thermo Fisher Scientific TMO +0.69% Get Free Report has outperformed the market over the past 20 years by 8.16% on an annualized basis producing an average annual return of 16.16%. Currently, Thermo Fisher Scientific has a market capitalization of $219.66 billion.
Thermo Fisher lifts profit forecast as medical equipment demand improves
Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and services used in drug development and sending shares up about 4% premarket.
7 Analysts Assess Thermo Fisher Scientific: What You Need To Know
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $628.14, along with a high estimate of $660.00 and a low estimate of $605.00. Marking an increase of 8.21%, the current average surpasses the previous average price target of $580.50.
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings
Thermo Fisher Scientific Inc. (NYSE:TMO) reported better-than-expected first-quarter financial results and raised its FY24 guidance on Wednesday. Thermo Fisher Scientific posted a first-quarter revenue of $10.
Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip
Thermo Fisher Scientific Q1 Profit Increases, beats estimates
Thermo Fisher Scientific (TMO) revealed earnings for its first quarter that increased from the same period last year and beat the
TMO Stock Earnings: Thermo Fisher Scientific Beats EPS, Beats Revenue for Q1 2024
Yahoo Finance1d
Thermo Fisher launches CXCL10 test for kidney transplant patients
Thermo Fisher Scientific has announced the launch of the CXCL10 testing service, designed to aid in the management of ...
Thermo Fisher Scientific extends $3.1 billion offer to acquire Olink Holdings of Sweden to June 18
Thermo Fisher Scientific, a maker of laboratory and health care equipment with Lehigh Valley operations, has extended its ...
Thermo Fisher Claims Competitor Repligen Poaches Employees
Thermo Fisher Scientific Inc. accused life sciences company Repligen Corp. of violating state consumer protection laws by ...
Thermo Fisher's Brammer Bio sues Boston Properties over Kendall construction
A lawsuit filed Friday marks an escalation in a protracted dispute between Brammer Bio and Boston Properties over some of the most valuable real estate in Massachusetts.
Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Thermo Fisher is expected to have near zero revenue and earnings growth in 2024. Find out why TMO stock is a Hold.
Morningstar1d
Thermo Fisher Scientific Inc TMO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Joplin Globe2d
Thermo Fisher Scientific Launches New CXCL10 Testing Service
Thermo Fisher Scientific One Lambda Laboratories, a CLIA facility in Fishers, Ind., has introduced a new CXCL10 testing service, which allows for non-invasive urine sample collection and testing, ...